In-silico analysis of 1,3-bis (P-hydroxyphenyl)urea as anti-inflammatory through inhibition of cox-1 and tnf-α

11Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A new compound of 1,3-bis(p-hydroxyphenyl) urea was designed and predicted to have fewer hepatotoxic side effects and as analgetic. Synthesis of 1,3-bis(p-hydroxyphenyl) urea could be carried out by reaction between p-aminophenol and urea. This study evaluated the mechanism of 1,3-bis(p-hydroxyphenyl) urea in inhibition of COX-1 and TNF-α with molecular docking. Docking was performed on the receptor file COX-1 (PDB ID: 1CQE) and TNF-α (PDB ID: 2AZ5) using AutoDock Vina PyRx 9.5 program and visualized by Ligplot 2.1 and PyMol 2.3.1. Two and three-dimension conformation models of compounds were generated by the MarvinSketch program. The docking score of ligand control, 1,3-bis(p-hydroxyphenyl) urea, diclofenac and dexamethasone towards 1CQE and 2AZ5 were-8.4;-10.6;-7.4 Kcal/mol and –9.2;-9.6; 7.1 Kcal/mol respectively. 1,3-bis(p-hydroxyphenyl) urea interacted with more amount of amino acid residues if compare with dexamethasone, diclofenac and ligand control.

Cite

CITATION STYLE

APA

Harahap, U., Purnomo, H., & Satria, D. (2021). In-silico analysis of 1,3-bis (P-hydroxyphenyl)urea as anti-inflammatory through inhibition of cox-1 and tnf-α. Rasayan Journal of Chemistry, 14(3), 1489–1492. https://doi.org/10.31788/RJC.2021.1436163

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free